JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
Myriad Genetics (MYGN) Shares Fall Amid JPMorgan Downgrade
-
Notable Analyst Rating Changes 05/13: MS, EBAY, S, MYGN, AUTH Upgraded; RAS, COF, SHPGY, JACK Downgraded
-
Unusual 11 Mid-Day Movers 5/5: PCBC, CSPI, AMMD, TX, ESE Higher; ITMN, MYGN, LNCE, CLMT Lower
-
Notable Analyst Rating Changes 05/05: S, CAb, ERTS, AMMD Upgraded; ITMN, MRK, NWSA, MYGN Downgraded
-
David Moenning's Daily State of the Markets: 8/26
-
Notable Analyst Rating Changes 8/4: HBC, HGSI, PKY, DISH, TLB Upgraded; HOLX, ATML, ABX, STEC, LAMR Downgraded
-
David Moenning's Daily State of the Markets: 7/1
-
Notable Analyst Rating Changes 7/1: YUM, TRW, MGA, MVL Upgraded; FRPT, NDAQ, BEAT, MYGN Downgraded
-
David Moenning's Daily State of the Markets: 11/04
-
JPMorgan Selects 26 Small, Mid-Cap Stocks That Can Outperform
-
Notable Analyst Rating Changes 10/08: BMY, NUE, SYMC Upgraded; TM, X, UPS, F, GM Downgraded
-
Myriad Genetics (MYGN) Considering Separation of Molecular Diagnostic and Pharmaceutical Business
-
Pre-Open Movers: Thornburg Mortgage (TMA) Sinks After Failing To Meet Margin Call, Blockbuster (BBI) Up on Results
